{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:45:02Z","timestamp":1793108702359,"version":"4.5.0"},"reference-count":262,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2020-MS-167"],"award-info":[{"award-number":["2020-MS-167"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Reproductive Immunology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jri.2022.103490","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T09:47:39Z","timestamp":1643449659000},"page":"103490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["The role of plasminogen activator inhibitor-1 in gynecological and obstetrical diseases: An update review"],"prefix":"10.1016","volume":"150","author":[{"given":"Jiaqi","family":"Zhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuhua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jri.2022.103490_bib1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3109\/14767058.2010.511331","article-title":"Polymorphisms of plasminogen activator inhibitor-1, angiotensin converting enzyme and coagulation factor xiii genes in patients with recurrent spontaneous abortion","volume":"24","author":"Aarabi","year":"2011","journal-title":"J. Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jri.2022.103490_bib2","first-page":"156","article-title":"Association between - 675 id, 4g\/5g pai-1 gene polymorphism and pregnancy loss: A systematic review","volume":"26","author":"Adler","year":"2018","journal-title":"Acta Inform. Med.: AIM: J. Soc. Med. Inform. Bosnia Herzeg.: Cas. Drustva za Med. Inform. BiH."},{"key":"10.1016\/j.jri.2022.103490_bib3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4103\/0300-1652.188337","article-title":"Utility of a single mid-trimester measurement of plasminogen activator type 1 and fibronectin to predict preeclampsia in pregnancy","volume":"57","author":"Ajibola","year":"2016","journal-title":"Niger. Med. J.: J. Niger. Med. Assoc."},{"key":"10.1016\/j.jri.2022.103490_bib4","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.diabres.2008.07.014","article-title":"Serum osteoprotegerin is associated with carotid intima media thickness in women with previous gestational diabetes","volume":"82","author":"Akinci","year":"2008","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.jri.2022.103490_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000273067","article-title":"Polymorphisms in nos3, ace and pai-1 genes and risk of spontaneous recurrent miscarriage in the gaza strip","volume":"19","author":"Al Sallout","year":"2010","journal-title":"Med. Princ. Pract.: Int. J. Kuwait Univ., Health Sci. Cent."},{"key":"10.1016\/j.jri.2022.103490_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219064","article-title":"Plasminogen activator inhibitor-1 (pai-1) expression in endometriosis","volume":"14","author":"Alotaibi","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.jri.2022.103490_bib7","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0026-0495(95)90118-3","article-title":"Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome","volume":"44","author":"Andersen","year":"1995","journal-title":"Metab.: Clin. Exp."},{"key":"10.1016\/j.jri.2022.103490_bib8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.placenta.2012.02.013","article-title":"Placental expression of vegf family mrna in adverse pregnancy outcomes","volume":"33","author":"Andraweera","year":"2012","journal-title":"Placenta"},{"key":"10.1016\/j.jri.2022.103490_bib9","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.fertnstert.2012.06.048","article-title":"Evaluation and treatment of recurrent pregnancy loss: A committee opinion","volume":"98","author":"Anon","year":"2012","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jri.2022.103490_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.fertnstert.2012.09.023","article-title":"Definitions of infertility and recurrent pregnancy loss: A committee opinion","volume":"99","author":"Anon","year":"2013","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jri.2022.103490_bib11","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1097\/AOG.0000000000002703","article-title":"Acog practice bulletin no. 197: Inherited thrombophilias in pregnancy","volume":"132","author":"Anon","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jri.2022.103490_bib12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/molehr\/gah031","article-title":"Vascular endothelial growth factor, epidermal growth factor and fibroblast growth factor-4 and -10 stimulate trophoblast plasminogen activator system and metalloproteinase-9","volume":"10","author":"Anteby","year":"2004","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.jri.2022.103490_bib13","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1046\/j.1365-2265.2000.00946.x","article-title":"Raised plasminogen activator inhibitor-1 (pai-1) is not an independent risk factor in the polycystic ovary syndrome (pcos)","volume":"52","author":"Atiomo","year":"2000","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.jri.2022.103490_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/molehr\/gan072","article-title":"Plasminogen activator inhibitor-1 4g\/5g and 5,10-methylene-tetrahydrofolate reductase c677t polymorphisms in polycystic ovary syndrome","volume":"15","author":"Bagos","year":"2009","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.jri.2022.103490_bib15","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0002-9378(89)90537-1","article-title":"Predictive value of increased plasma levels of fibronectin in gestational hypertension","volume":"161","author":"Ballegeer","year":"1989","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jri.2022.103490_bib16","doi-asserted-by":"crossref","first-page":"504","DOI":"10.5603\/GP.2016.0034","article-title":"Correlation between factor vii and pai-1 genetic variants and recurrent miscarriage","volume":"87","author":"Barlik","year":"2016","journal-title":"Ginekol. Pol."},{"key":"10.1016\/j.jri.2022.103490_bib17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1746-1596-5-24","article-title":"Intrauterine growth restriction and placental angiogenesis","volume":"5","author":"Barut","year":"2010","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.jri.2022.103490_bib18","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.12659\/MSM.908832","article-title":"Thrombophilia and recurrent pregnancy loss: The enigma continues","volume":"24","author":"Barut","year":"2018","journal-title":"Med. Sci. Monit.: Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.jri.2022.103490_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12958-018-0414-2","article-title":"Recurrent implantation failure-update overview on etiology, diagnosis, treatment and future directions","volume":"16","author":"Bashiri","year":"2018","journal-title":"Reprod. Biol. Endocrinol.: RBE"},{"key":"10.1016\/j.jri.2022.103490_bib20","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/bloodadvances.2018024802","article-title":"American society of hematology 2018 guidelines for management of venous thromboembolism: Venous thromboembolism in the context of pregnancy","volume":"2","author":"Bates","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.jri.2022.103490_bib21","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1210\/jc.2003-031351","article-title":"Tumor necrosis factor-alpha inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous explant cultures","volume":"89","author":"Bauer","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jri.2022.103490_bib22","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/01.AOG.0000220517.53892.0a","article-title":"Genetic polymorphism in the fibrinolytic system and endometriosis","volume":"108","author":"Bedaiwy","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jri.2022.103490_bib23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-2007-993903","article-title":"Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation","volume":"15","author":"Bellart","year":"1998","journal-title":"Am. J. Perinatol."},{"key":"10.1016\/j.jri.2022.103490_bib24","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0104-4230(11)70093-8","article-title":"Environmental factors and endometriosis","volume":"57","author":"Bellelis","year":"2011","journal-title":"Rev. da Assoc. Med. Bras. (1992). 57"},{"key":"10.1016\/j.jri.2022.103490_bib25","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/19396368.2018.1456576","article-title":"Association between thrombophilia gene polymorphisms and recurrent pregnancy loss risk in the iranian population","volume":"64","author":"Bigdeli","year":"2018","journal-title":"Syst. Biol. Reprod. Med."},{"key":"10.1016\/j.jri.2022.103490_bib26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1155\/2011\/219350","article-title":"Fibronectin, plasminogen activator inhibitor type 1 (pai-1) and uterine artery doppler velocimetry as markers of preeclampsia","volume":"30","author":"Bodova","year":"2011","journal-title":"Dis. Markers"},{"key":"10.1016\/j.jri.2022.103490_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/790605","article-title":"Circulating levels of inflammatory markers in intrauterine growth restriction","volume":"2010","author":"Boutsikou","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jri.2022.103490_bib28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/0885066604269663","article-title":"Current concepts in intrauterine growth restriction","volume":"19","author":"Brodsky","year":"2004","journal-title":"J. Intensive Care Med."},{"key":"10.1016\/j.jri.2022.103490_bib29","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0015-0282(98)00285-4","article-title":"Fibrinolytic factors in endometriotic tissue, endometrium, peritoneal fluid, and plasma from women with endometriosis and in endometrium and peritoneal fluid from healthy women","volume":"70","author":"Bruse","year":"1998","journal-title":"Fertil. Steril."},{"issue":"Suppl 1","key":"10.1016\/j.jri.2022.103490_bib30","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.fertnstert.2004.09.033","article-title":"Basal release of urokinase plasminogen activator, plasminogen activator inhibitor-1, and soluble plasminogen activator receptor from separated and cultured endometriotic and endometrial stromal and epithelial cells","volume":"83","author":"Bruse","year":"2005","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jri.2022.103490_bib31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/molehr\/gah033","article-title":"In situ localization of mrna for the fibrinolytic factors upa, pai-1 and upar in endometriotic and endometrial tissue","volume":"10","author":"Bruse","year":"2004","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.jri.2022.103490_bib32","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1093\/humrep\/deg474","article-title":"Polymorphisms in the ace and pai-1 genes are associated with recurrent spontaneous miscarriages","volume":"18","author":"Buchholz","year":"2003","journal-title":"Hum. Reprod. (Oxf., Engl. )"},{"key":"10.1016\/j.jri.2022.103490_bib33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1034\/j.1600-0897.2003.00049.x","article-title":"Inherited thrombophilia: Impact on human reproduction","volume":"50","author":"Buchholz","year":"2003","journal-title":"Am. J. Reprod. Immunol. (N. Y., N. Y.: 1989)"},{"key":"10.1016\/j.jri.2022.103490_bib34","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1177\/1933719117698576","article-title":"The influence of lipid and proinflammatory status on maternal uterine blood flow in women with late onset gestational diabetes","volume":"25","author":"Bugatto","year":"2018","journal-title":"Reprod. Sci. (Thousand Oaks, Calif. )"},{"key":"10.1016\/j.jri.2022.103490_bib35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12958-019-0472-0","article-title":"Expression of the plasminogen system in the physiological mouse ovary and in the pathological polycystic ovary syndrome (pcos) state","volume":"17","author":"Burchall","year":"2019","journal-title":"Reprod. Biol. Endocrinol.: RBE"},{"key":"10.1016\/j.jri.2022.103490_bib36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.thromres.2008.02.007","article-title":"Relationship between maternal and cord blood hemostatic disturbances in preeclamptic pregnancies","volume":"123","author":"Catarino","year":"2008","journal-title":"Thromb. Res"},{"key":"10.1016\/j.jri.2022.103490_bib37","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1111\/j.1755-5922.2010.00171.x","article-title":"Plasminogen activator inhibitor-1 (pai-1): A key factor linking fibrinolysis and age-related subclinical and clinical conditions","volume":"28","author":"Cesari","year":"2010","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.jri.2022.103490_bib38","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2141.2005.05444.x","article-title":"Molecular mechanisms of fibrinolysis","volume":"129","author":"Cesarman-Maus","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jri.2022.103490_bib39","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1139\/y02-016","article-title":"Regulation of human trophoblast migration and invasiveness","volume":"80","author":"Chakraborty","year":"2002","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.jri.2022.103490_bib40","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ajog.2004.04.045","article-title":"A practical approach to the diagnosis of polycystic ovary syndrome","volume":"191","author":"Chang","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jri.2022.103490_bib41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1067\/mob.2002.122969","article-title":"A longitudinal study of biochemical variables in women at risk of preeclampsia","volume":"187","author":"Chappell","year":"2002","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jri.2022.103490_bib42","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.placenta.2003.10.004","article-title":"Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation","volume":"25","author":"Charnock-Jones","year":"2004","journal-title":"Placenta"},{"key":"10.1016\/j.jri.2022.103490_bib43","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/ijlh.12703","article-title":"Thrombophilic gene polymorphisms and recurrent pregnancy loss in greek women","volume":"39","author":"Chatzidimitriou","year":"2017","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.jri.2022.103490_bib44","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/aji.12321","article-title":"Association between plasminogen activator inhibitor-1 gene polymorphisms and recurrent pregnancy loss: A systematic review and meta-analysis","volume":"73","author":"Chen","year":"2015","journal-title":"Am. J. Reprod. Immunol. (N. Y., N. Y.: 1989)"},{"key":"10.1016\/j.jri.2022.103490_bib45","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1161\/01.ATV.20.12.2696","article-title":"Identification and localization of a fatty acid response region in the human plasminogen activator inhibitor-1 gene","volume":"20","author":"Chen","year":"2000","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"key":"10.1016\/j.jri.2022.103490_bib46","doi-asserted-by":"crossref","first-page":"8225","DOI":"10.1074\/jbc.273.14.8225","article-title":"Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells","volume":"273","author":"Chen","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jri.2022.103490_bib47","unstructured":"Chew, L.C., Verma, R.P., 2021, Fetal growth restriction. Statpearls. StatPearls Publishing."},{"key":"10.1016\/j.jri.2022.103490_bib48","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00277-002-0549-1","article-title":"Tissue plasminogen activator levels change with plasma fibrinogen concentrations during pregnancy","volume":"81","author":"Choi","year":"2002","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.jri.2022.103490_bib49","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/jcp.22907","article-title":"Possible role of rkip in cytotrophoblast migration: Immunohistochemical and in vitro studies","volume":"227","author":"Ciarmela","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jri.2022.103490_bib50","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.3109\/14767058.2011.643326","article-title":"Recurrence and severity of abnormal pregnancy outcome in patients treated by low-molecular-weight heparin: A prospective pilot study","volume":"25","author":"Conserva","year":"2012","journal-title":"J. Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jri.2022.103490_bib51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1600-0897.1997.tb00277.x","article-title":"Current clinical options for diagnosis and treatment of recurrent spontaneous abortion. Clinical guidelines recommendation committee for diagnosis and treatment of recurrent spontaneous abortion","volume":"38","author":"Coulam","year":"1997","journal-title":"Am. J. Reprod. Immunol. (N. Y., N. Y.: 1989)"},{"key":"10.1016\/j.jri.2022.103490_bib52","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1472-6483(10)61004-8","article-title":"Multiple thrombophilic gene mutations are risk factors for implantation failure","volume":"12","author":"Coulam","year":"2006","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.jri.2022.103490_bib53","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1600-0897.2006.00376.x","article-title":"Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage","volume":"55","author":"Coulam","year":"2006","journal-title":"Am. J. Reprod. Immunol. (N. Y., N. Y.: 1989)"},{"key":"10.1016\/j.jri.2022.103490_bib54","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1600-0897.2008.00640.x","article-title":"Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis","volume":"60","author":"Coulam","year":"2008","journal-title":"Am. J. Reprod. Immunol. (N. Y., N. Y.: 1989)"},{"key":"10.1016\/j.jri.2022.103490_bib55","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1091\/mbc.12.5.1467","article-title":"Direct binding of occupied urokinase receptor (upar) to ldl receptor-related protein is required for endocytosis of upar and regulation of cell surface urokinase activity","volume":"12","author":"Czekay","year":"2001","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jri.2022.103490_bib56","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bcmd.2006.07.005","article-title":"Relationship between polymorphisms in thrombophilic genes and preeclampsia in a brazilian population","volume":"37","author":"Dalm\u00e1z","year":"2006","journal-title":"Blood Cells, Mol. Dis."},{"key":"10.1016\/j.jri.2022.103490_bib57","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/0002-9378(88)90016-6","article-title":"Placental-type plasminogen activator inhibitor in preeclampsia","volume":"158","author":"De Boer","year":"1988","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jri.2022.103490_bib58","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/j.1538-7836.2004.00861.x","article-title":"Preeclampsia and its interaction with common variants in thrombophilia genes","volume":"2","author":"De Maat","year":"2004","journal-title":"J. Thromb. Haemost.: JTH"},{"key":"10.1016\/j.jri.2022.103490_bib59","doi-asserted-by":"crossref","first-page":"22595","DOI":"10.1074\/jbc.M313004200","article-title":"The low density lipoprotein receptor-related protein is a motogenic receptor for plasminogen activator inhibitor-1","volume":"279","author":"Degryse","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jri.2022.103490_bib60","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-5793(01)02797-1","article-title":"Pai-1 inhibits urokinase-induced chemotaxis by internalizing the urokinase receptor","volume":"505","author":"Degryse","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jri.2022.103490_bib61","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1677\/JME-06-0057","article-title":"Transgenic overexpression of plasminogen activator inhibitor-1 promotes the development of polycystic ovarian changes in female mice","volume":"39","author":"Devin","year":"2007","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.jri.2022.103490_bib62","first-page":"113","article-title":"Effects of preeclampsia and eclampsia on cord blood coagulation tests","volume":"22","author":"Djelmis","year":"1998","journal-title":"Coll. Antropol."},{"key":"10.1016\/j.jri.2022.103490_bib63","first-page":"759","article-title":"Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia","volume":"109","author":"Djurovic","year":"2002","journal-title":"BJOG: Int. J. Obstet. Gynaecol."},{"key":"10.1016\/j.jri.2022.103490_bib64","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1373\/49.7.1081","article-title":"Plasminogen activator inhibitor 1 4g\/5g polymorphism and coagulation factor xiii val34leu polymorphism: Impaired fibrinolysis and early pregnancy loss","volume":"49","author":"Dossenbach-Glaninger","year":"2003","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jri.2022.103490_bib65","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1186\/s13058-014-0428-4","article-title":"Upa and pai-1 as biomarkers in breast cancer: Validated for clinical use in level-of-evidence-1 studies","volume":"16","author":"Duffy","year":"2014","journal-title":"Breast Cancer Res.: BCR"},{"key":"10.1016\/j.jri.2022.103490_bib66","first-page":"23","article-title":"[ivf failures: Maternal thrombophilia as a possible cause]","author":"Dzhandzhgava Zh","year":"2005","journal-title":"Georgian Med. N."},{"key":"10.1016\/j.jri.2022.103490_bib67","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/09513590.2016.1203893","article-title":"Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries","volume":"33","author":"Elci","year":"2017","journal-title":"Gynecol. Endocrinol.: Off. J. Int. Soc. Gynecol. Endocrinol."},{"key":"10.1016\/j.jri.2022.103490_bib68","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jri.2014.02.007","article-title":"Prevalence of coagulation factor xiii and plasminogen activator inhibitor-1 gene polymorphisms among egyptian women suffering from unexplained primary recurrent miscarriage","volume":"103","author":"Elmahgoub","year":"2014","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2022.103490_bib69","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/10641955.2016.1211676","article-title":"Fibrinolysis parameters in sudanese women with severe preeclampsia","volume":"35","author":"Elzein","year":"2016","journal-title":"Hypertens. Pregnancy"},{"key":"10.1016\/j.jri.2022.103490_bib70","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/01.ATV.18.1.20","article-title":"Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia","volume":"18","author":"Eriksson","year":"1998","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"key":"10.1016\/j.jri.2022.103490_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030508","article-title":"Inhibition of histone deacetylase activity in human endometrial stromal cells promotes extracellular matrix remodelling and limits embryo invasion","volume":"7","author":"Estella","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.jri.2022.103490_bib72","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1182\/blood.V74.4.1332.1332","article-title":"Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia","volume":"74","author":"Estell\u00e9s","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.jri.2022.103490_bib73","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0002-9378(91)90242-J","article-title":"Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia","volume":"165","author":"Estell\u00e9s","year":"1991","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jri.2022.103490_bib74","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1055\/s-0037-1614933","article-title":"Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia","volume":"79","author":"Estell\u00e9s","year":"1998","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jri.2022.103490_bib75","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1182\/blood.V84.1.143.143","article-title":"Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and\/or intrauterine fetal growth retardation","volume":"84","author":"Estell\u00e9s","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jri.2022.103490_bib76","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000072326","article-title":"Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia","volume":"56","author":"Fabbro","year":"2003","journal-title":"Gynecol. Obstet. Investig."},{"key":"10.1016\/j.jri.2022.103490_bib77","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2362.2006.01630.x","article-title":"Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes","volume":"36","author":"Farhan","year":"2006","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.jri.2022.103490_bib78","doi-asserted-by":"crossref","first-page":"12412","DOI":"10.1016\/S0021-9258(18)42289-2","article-title":"Post-transcriptional regulation of expression of plasminogen activator inhibitor type 1 mrna by insulin and insulin-like growth factor 1","volume":"267","author":"Fattal","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jri.2022.103490_bib79","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1053\/plac.1999.0446","article-title":"Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation","volume":"21","author":"Feng","year":"2000","journal-title":"Placenta"},{"issue":"Suppl 2","key":"10.1016\/j.jri.2022.103490_bib80","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.2337\/dc07-s206","article-title":"Increasing prevalence of gestational diabetes mellitus: A public health perspective","volume":"30","author":"Ferrara","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jri.2022.103490_bib81","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1161\/01.CIR.0000066908.82782.3A","article-title":"Promoter (4g\/5g) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, hispanics, and non-hispanic whites: The insulin resistance atherosclerosis study","volume":"107","author":"Festa","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jri.2022.103490_bib82","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1182\/blood.V99.6.2077","article-title":"Identification of a tightly regulated hypoxia-response element in the promoter of human plasminogen activator inhibitor-1","volume":"99","author":"Fink","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jri.2022.103490_bib83","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/excr.1998.4240","article-title":"Stimulation of plasminogen activator inhibitor-1 expression in immortalized human trophoblast cells cultured under low levels of oxygen","volume":"245","author":"Fitzpatrick","year":"1998","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jri.2022.103490_bib84","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1053\/plac.2000.0573","article-title":"Does plasminogen activator inhibitor-1 (pai-1) control trophoblast invasion? A study of fetal and maternal tissue in intrauterine, tubal and molar pregnancies","volume":"21","author":"Floridon","year":"2000","journal-title":"Placenta"},{"key":"10.1016\/j.jri.2022.103490_bib85","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0002-9378(95)90113-2","article-title":"Biochemical corroboration of endothelial involvement in severe preeclampsia","volume":"172","author":"Friedman","year":"1995","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jri.2022.103490_bib86","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jpag.2016.03.004","article-title":"Adolescents with classical polycystic ovary syndrome have alterations in the surrogate markers of cardiovascular disease but not in the endothelial function. The possible benefits of metformin","volume":"29","author":"Fruzzetti","year":"2016","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"10.1016\/j.jri.2022.103490_bib87","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3109\/09513590.2010.508543","article-title":"Association of the t45g and g276t polymorphisms in the adiponectin gene with pcos: A meta-analysis","volume":"28","author":"Gao","year":"2012","journal-title":"Gynecol. Endocrinol.: Off. J. Int. Soc. Gynecol. Endocrinol."},{"key":"10.1016\/j.jri.2022.103490_bib88","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1447-0756.1996.tb00928.x","article-title":"The imbalance of plasminogen activators and inhibitor in preeclampsia","volume":"22","author":"Gao","year":"1996","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.jri.2022.103490_bib89","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejogrb.2009.06.008","article-title":"Plasminogen activator inhibitor-1 4g\/5g polymorphism and susceptibility to endometriosis in the italian population","volume":"146","author":"Gentilini","year":"2009","journal-title":"Eur. J. Obstet., Gynecol., Reprod. Biol."},{"key":"10.1016\/j.jri.2022.103490_bib90","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1538-7836.2005.01226.x","article-title":"The g20210a prothrombin-gene mutation and the plasminogen activator inhibitor (pai-1) 5g\/5g genotype are associated with early onset of severe preeclampsia","volume":"3","author":"Gerhardt","year":"2005","journal-title":"J. Thromb. Haemost.: JTH"},{"key":"10.1016\/j.jri.2022.103490_bib91","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jcp.22783","article-title":"Pai-1 in tissue fibrosis","volume":"227","author":"Ghosh","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jri.2022.103490_bib92","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/uog.18959","article-title":"Genetic and non-genetic risk factors for pre-eclampsia: Umbrella review of systematic reviews and meta-analyses of observational studies","volume":"51","author":"Giannakou","year":"2018","journal-title":"Ultrasound Obstet. Gynecol.: Off. J. Int. Soc. Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.jri.2022.103490_bib93","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.2741\/1609","article-title":"Plasminogen activators and plasminogen activator inhibitors in endometriosis","volume":"10","author":"Gilabert-Estelles","year":"2005","journal-title":"Front. Biosci.: a J. Virtual Libr."},{"key":"10.1016\/j.jri.2022.103490_bib94","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/humrep\/deg300","article-title":"Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis","volume":"18","author":"Gilabert-Estell\u00e9s","year":"2003","journal-title":"Hum. Reprod. (Oxf., Engl. )"},{"key":"10.1016\/j.jri.2022.103490_bib95","first-page":"179","article-title":"The pathophysiological relevance of pai-1 in cardiovascular diseases and the development of monoclonal antibodies as pai-1 inhibitors","volume":"68","author":"Gils","year":"2006","journal-title":"Verh. - K. Acad. voor Geneeskd. Van. Belg."},{"key":"10.1016\/j.jri.2022.103490_bib96","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1160\/TH03-12-0764","article-title":"The structural basis for the pathophysiological relevance of pai-i in cardiovascular diseases and the development of potential pai-i inhibitors","volume":"91","author":"Gils","year":"2004","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jri.2022.103490_bib97","first-page":"252","article-title":"Status of current research on endometriosis","volume":"43","author":"Giudice","year":"1998","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.jri.2022.103490_bib98","first-page":"44","article-title":"Genetic hypofibrinolysis in complicated pregnancies","volume":"97","author":"Glueck","year":"2001","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jri.2022.103490_bib99","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.metabol.2005.09.008","article-title":"Plasminogen activator inhibitor activity, 4g5g polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome","volume":"55","author":"Glueck","year":"2006","journal-title":"Metab.: Clin. Exp."},{"key":"10.1016\/j.jri.2022.103490_bib100","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0026-0495(99)90250-0","article-title":"Plasminogen activator inhibitor activity: An independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome","volume":"48","author":"Glueck","year":"1999","journal-title":"Metab.: Clin. Exp."},{"key":"10.1016\/j.jri.2022.103490_bib101","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1600-0412.2011.01086.x","article-title":"Plasminogen activator inhibitor-1 4g\/5g polymorphism in infertile women with and without endometriosis","volume":"90","author":"Gon\u00e7alves-Filho","year":"2011","journal-title":"Acta Obstet. Et. Gynecol. Scand."},{"key":"10.1016\/j.jri.2022.103490_bib102","first-page":"219","article-title":"Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis. Nature reviews","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.jri.2022.103490_bib103","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1600-0897.2009.00744.x","article-title":"Are polymorphisms in the ace and pai-1 genes associated with recurrent spontaneous miscarriages?","volume":"62","author":"Goodman","year":"2009","journal-title":"Am. J. Reprod. Immunol. (N. Y., N. Y.: 1989)"},{"key":"10.1016\/j.jri.2022.103490_bib104","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1600-0897.2006.00419.x","article-title":"Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss?","volume":"56","author":"Goodman","year":"2006","journal-title":"Am. J. Reprod. Immunol. (N. Y., N. Y.: 1989)"},{"key":"10.1016\/j.jri.2022.103490_bib105","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/0002-9378(87)90076-7","article-title":"Pregnancy-induced changes in the fibrinolytic balance: Evidence for defective release of tissue plasminogen activator and increased levels of the fast-acting tissue plasminogen activator inhibitor","volume":"156","author":"Gore","year":"1987","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jri.2022.103490_bib106","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jcp.37.1.56","article-title":"The fibrinolytic system in pre-eclampsia","volume":"37","author":"Gow","year":"1984","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jri.2022.103490_bib107","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1055\/s-0038-1656119","article-title":"Respective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. The nimes obstetricians and haematologists (noha) study","volume":"77","author":"Gris","year":"1997","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jri.2022.103490_bib108","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0049-3848(96)00211-3","article-title":"A novel g\/a and the 4g\/5g polymorphism within the promoter of the plasminogen activator inhibitor-1 gene in patients with deep vein thrombosis","volume":"84","author":"Grubic","year":"1996","journal-title":"Thromb. Res"},{"key":"10.1016\/j.jri.2022.103490_bib109","first-page":"330","article-title":"[association of genetic polymorphisms in plasminogen activator inhibitor-1 gene and 5,10-methylenetetrahydrofolate reductase gene with recurrent early spontaneous abortion]","volume":"22","author":"Guan","year":"2005","journal-title":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chin. J. Med. Genet."},{"key":"10.1016\/j.jri.2022.103490_bib110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000068950","article-title":"Impact of epidermal growth factor and transforming growth factor beta-1 on the release of fibrinolytic factors from cultured endometrial and ovarian endometriotic stromal cells","volume":"55","author":"Guan","year":"2003","journal-title":"Gynecol. Obstet. Investig."},{"key":"10.1016\/j.jri.2022.103490_bib111","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1196\/annals.1434.015","article-title":"The placental syncytium and the pathophysiology of preeclampsia and intrauterine growth restriction: A novel assay to assess syncytial protein expression","volume":"1127","author":"Guller","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jri.2022.103490_bib112","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/109065703322537313","article-title":"Plasminogen activator inhibitor-1 polymorphism in women with pre-eclampsia","volume":"7","author":"H\u00e4kli","year":"2003","journal-title":"Genet. Test."},{"key":"10.1016\/j.jri.2022.103490_bib113","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.preghy.2012.01.004","article-title":"Coagulation and fibrinolytic system protein profiles in women with normal pregnancies and pregnancies complicated by hypertension","volume":"2","author":"Hale","year":"2012","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.jri.2022.103490_bib114","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1471-0528.1994.tb13147.x","article-title":"Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia","volume":"101","author":"Halligan","year":"1994","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.jri.2022.103490_bib115","doi-asserted-by":"crossref","first-page":"19095","DOI":"10.1016\/S0021-9258(17)32279-2","article-title":"Induction of plasminogen activator inhibitor-1 in hepg2 human hepatoma cells by mediators of the acute phase response","volume":"269","author":"Healy","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jri.2022.103490_bib116","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1210\/jc.2004-2494","article-title":"Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus","volume":"90","author":"Heitritter","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jri.2022.103490_bib117","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2003-38897","article-title":"Hemostasis during normal pregnancy and puerperium","volume":"29","author":"Hellgren","year":"2003","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.jri.2022.103490_bib118","first-page":"g1752","article-title":"Endometriosis","volume":"348","author":"Hickey","year":"2014","journal-title":"BMJ (Clin. Res. Ed. )"},{"key":"10.1016\/j.jri.2022.103490_bib119","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0049-3848(00)00267-X","article-title":"The effect of pre-eclampsia on coagulation and fibrinolytic activation in the neonate","volume":"99","author":"Higgins","year":"2000","journal-title":"Thromb. Res"},{"key":"10.1016\/j.jri.2022.103490_bib120","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0002-9378(98)70389-8","article-title":"Hemostasis in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnancies","volume":"179","author":"Higgins","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jri.2022.103490_bib121","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1055\/s-0038-1648415","article-title":"The predictive value of the hemostasis parameters in the development of preeclampsia","volume":"67","author":"Ho","year":"1992","journal-title":"Thromb. Haemost."},{"issue":"Pt 2","key":"10.1016\/j.jri.2022.103490_bib122","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1469-7580.1999.19420183.x","article-title":"Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta","volume":"194","author":"Hu","year":"1999","journal-title":"J. Anat."},{"key":"10.1016\/j.jri.2022.103490_bib123","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.placenta.2005.02.012","article-title":"Tnfalpha-mediated induction of pai-1 restricts invasion of htr-8\/svneo trophoblast cells","volume":"27","author":"Huber","year":"2006","journal-title":"Placenta"},{"key":"10.1016\/j.jri.2022.103490_bib124","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1538-7836.2009.03344.x","article-title":"Pregnancy outcome and fibrinolytic, endothelial and coagulation markers in women undergoing uterine artery doppler screening at 23 weeks","volume":"7","author":"Hunt","year":"2009","journal-title":"J. Thromb. Haemost.: JTH"},{"key":"10.1016\/j.jri.2022.103490_bib125","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/aji.12002","article-title":"Plasminogen activator inhibitor 1 and methylenetetrahydrofolate reductase gene mutations in iranian women with polycystic ovary syndrome","volume":"68","author":"Idali","year":"2012","journal-title":"Am. J. Reprod. Immunol. (N. Y., N. Y.: 1989)"},{"key":"10.1016\/j.jri.2022.103490_bib126","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/01.ede.0000158199.64871.b9","article-title":"Thrombophilic polymorphisms and intrauterine growth restriction","volume":"16","author":"Infante-Rivard","year":"2005","journal-title":"Epidemiol. (Camb., Mass. )"},{"key":"10.1016\/j.jri.2022.103490_bib127","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.placenta.2008.06.011","article-title":"The functional role of the renin-angiotensin system in pregnancy and preeclampsia","volume":"29","author":"Irani","year":"2008","journal-title":"Placenta"},{"key":"10.1016\/j.jri.2022.103490_bib128","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/576926","article-title":"High fasting insulin levels and insulin resistance may be linked to idiopathic recurrent pregnancy loss: A case-control study","volume":"2013","author":"Ispasoiu","year":"2013","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.jri.2022.103490_bib129","first-page":"3","article-title":"[plasminogen activator inhibitor type 1 activity in women with unexplained very early recurrent pregnancy loss]","volume":"49","author":"Ivanov","year":"2010","journal-title":"Akusherstvo i Ginekol."},{"key":"10.1016\/j.jri.2022.103490_bib130","first-page":"8","article-title":"[combined thrombophilic factors among women with late recurrent spontaneous abortions]","volume":"50","author":"Ivanov","year":"2011","journal-title":"Akusherstvo i Ginekol."},{"key":"10.1016\/j.jri.2022.103490_bib131","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1600-0897.2012.01156.x","article-title":"Inherited thrombophilia and ivf failure: The impact of coagulation disorders on implantation process","volume":"68","author":"Ivanov","year":"2012","journal-title":"Am. J. Reprod. Immunol. (N. Y., N. Y.: 1989)"},{"key":"10.1016\/j.jri.2022.103490_bib132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4093\/dmj.2011.35.1.1","article-title":"Gestational diabetes in korea: Incidence and risk factors of diabetes in women with previous gestational diabetes","volume":"35","author":"Jang","year":"2011","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.jri.2022.103490_bib133","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2796.1991.tb00352.x","article-title":"Hypo-fibrinolysis in patients with hypertension and elevated cholesterol","volume":"229","author":"Jansson","year":"1991","journal-title":"J. Intern Med"},{"key":"10.1016\/j.jri.2022.103490_bib134","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-0897.2010.00974.x","article-title":"Analysis of plasminogen activator inhibitor-1, integrin beta3, beta fibrinogen, and methylenetetrahydrofolate reductase polymorphisms in iranian women with recurrent pregnancy loss","volume":"66","author":"Jeddi-Tehrani","year":"2011","journal-title":"Am. J. Reprod. Immunol. (N. Y., N. Y.: 1989)"},{"key":"10.1016\/j.jri.2022.103490_bib135","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1160\/TH13-03-0242","article-title":"Genetic association of five plasminogen activator inhibitor-1 (pai-1) polymorphisms and idiopathic recurrent pregnancy loss in korean women","volume":"110","author":"Jeon","year":"2013","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jri.2022.103490_bib136","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s12020-012-9605-3","article-title":"Associations of adiponectin gene polymorphisms with polycystic ovary syndrome: A meta-analysis","volume":"42","author":"Jia","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.jri.2022.103490_bib137","first-page":"199","article-title":"Combined presence of coagulation factor xiii v34l and plasminogen activator inhibitor 1 4g\/5g gene polymorphisms significantly contribute to recurrent pregnancy loss in serbian population","volume":"39","author":"Joksic","year":"2020","journal-title":"J. Med. Biochem."},{"key":"10.1016\/j.jri.2022.103490_bib138","first-page":"158","article-title":"The association of factor v g1961a (factor v leiden), prothrombin g20210a, mthfr c677t and pai-1 4g\/5g polymorphisms with recurrent pregnancy loss in bosnian women","volume":"15","author":"Jusi\u0107","year":"2018","journal-title":"Med. Glas.: Off. Publ. Med. Assoc. Zenica-Doboj. Cant., Bosnia Herzeg."},{"key":"10.1016\/j.jri.2022.103490_bib139","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2310\/JIM.0b013e31822c5bdf","article-title":"Do serum angiopoietin-1, angiopoietin-2, and their receptor tie-2 and 4g\/5g variant of pai-1 gene have a role in the pathogenesis of preeclampsia?","volume":"59","author":"Kamal","year":"2011","journal-title":"J. Invest. Med.: Off. Publ. Am. Fed. Clin. Res."},{"key":"10.1016\/j.jri.2022.103490_bib140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1095\/biolreprod.102.014977","article-title":"Endovascular trophoblast invasion: Implications for the pathogenesis of intrauterine growth retardation and preeclampsia","volume":"69","author":"Kaufmann","year":"2003","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.jri.2022.103490_bib141","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10815-013-0125-8","article-title":"Association between plasminogen activator inhibitor 1 gene mutation and different subgroups of recurrent miscarriage and implantation failure","volume":"31","author":"Khosravi","year":"2014","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.jri.2022.103490_bib142","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/gtmb.2010.0251","article-title":"Plasminogen activator inhibitor type-1 gene 4g\/5g polymorphism and polycystic ovary syndrome","volume":"15","author":"Kilicci","year":"2011","journal-title":"Genet. Test. Mol. Biomark."},{"key":"10.1016\/j.jri.2022.103490_bib143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4093\/dmj.2014.38.1.1","article-title":"Gestational diabetes mellitus in korean women: Similarities and differences from other racial\/ethnic groups","volume":"38","author":"Kim","year":"2014","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.jri.2022.103490_bib144","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.2337\/diacare.25.10.1862","article-title":"Gestational diabetes and the incidence of type 2 diabetes: A systematic review","volume":"25","author":"Kim","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jri.2022.103490_bib145","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1161\/01.ATV.17.11.3242","article-title":"Polymorphism of angiotensin converting enzyme gene is associated with circulating levels of plasminogen activator inhibitor-1","volume":"17","author":"Kim","year":"1997","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"key":"10.1016\/j.jri.2022.103490_bib146","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/aji.12302","article-title":"The pai-1 4g\/5g and ace i\/d polymorphisms and risk of recurrent pregnancy loss: A case-control study","volume":"72","author":"Kim","year":"2014","journal-title":"Am. J. Reprod. Immunol. (N. Y., N. Y.: 1989)"},{"key":"10.1016\/j.jri.2022.103490_bib147","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/dme.12387","article-title":"Changes in procoagulants track longitudinally with insulin resistance: Findings from the coronary artery risk development in young adults (cardia) study","volume":"31","author":"Klein","year":"2014","journal-title":"Diabet. Med.: a J. Br. Diabet. Assoc."},{"key":"10.1016\/j.jri.2022.103490_bib148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2188\/jea.16.1","article-title":"Genetic and environmental factors associated with the development of hypertension in pregnancy","volume":"16","author":"Kobashi","year":"2006","journal-title":"J. Epidemiol."},{"key":"10.1016\/j.jri.2022.103490_bib149","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2188\/jea.JE20090003","article-title":"4g\/5g variant of plasminogen activator inhibitor-1 gene and severe pregnancy-induced hypertension: Subgroup analyses of variants of angiotensinogen and endothelial nitric oxide synthase","volume":"19","author":"Kobashi","year":"2009","journal-title":"J. Epidemiol."},{"key":"10.1016\/j.jri.2022.103490_bib150","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000292703","article-title":"Plasminogen activators, plasminogen activator inhibitors and markers of intravascular coagulation in pre-eclampsia","volume":"35","author":"Koh","year":"1993","journal-title":"Gynecol. Obstet. Investig."},{"key":"10.1016\/j.jri.2022.103490_bib151","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1507\/endocrj.EJ11-0023","article-title":"Plasma plasminogen activator inhibitor-1 levels in the different phenotypes of the polycystic ovary syndrome","volume":"59","author":"Koiou","year":"2012","journal-title":"Endocr. J."},{"key":"10.1016\/j.jri.2022.103490_bib152","doi-asserted-by":"crossref","first-page":"559","DOI":"10.14310\/horm.2002.1444","article-title":"Disparate effects of pharmacotherapy on plasma plasminogen activator inhibitor-1 levels in women with the polycystic ovary syndrome","volume":"12","author":"Koiou","year":"2013","journal-title":"Horm. (Athens, Greece)"},{"key":"10.1016\/j.jri.2022.103490_bib153","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1182\/blood.V69.2.460.460","article-title":"Fibrinolysis in pregnancy: A study of plasminogen activator inhibitors","volume":"69","author":"Kruithof","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.jri.2022.103490_bib154","doi-asserted-by":"crossref","first-page":"271","DOI":"10.17772\/gp\/62203","article-title":"Coexistence of ace (i\/d) and pai-1 (4g\/5g) gene variants in recurrent miscarriage in polish population","volume":"87","author":"Kurzawi\u0144ska","year":"2016","journal-title":"Ginekol. Pol."},{"key":"10.1016\/j.jri.2022.103490_bib155","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1055\/s-2006-931801","article-title":"Thrombophilias and recurrent pregnancy loss","volume":"24","author":"Kutteh","year":"2006","journal-title":"Semin. Reprod. Med."},{"key":"10.1016\/j.jri.2022.103490_bib156","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1152\/physiolgenomics.00147.2010","article-title":"Transient reduction of placental angiogenesis in pai-1-deficient mice","volume":"43","author":"Labied","year":"2011","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.jri.2022.103490_bib157","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/sj.ejhg.5201011","article-title":"Genetic variation at the human tissue-type plasminogen activator (tpa) locus: Haplotypes and analysis of association to plasma levels of tpa","volume":"11","author":"Ladenvall","year":"2003","journal-title":"Eur. J. Hum. Genet.: EJHG"},{"key":"10.1016\/j.jri.2022.103490_bib158","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1447-0756.2010.01262.x","article-title":"Double inherited thrombophilias and adverse pregnancy outcomes: Fashion or science?","volume":"36","author":"Larciprete","year":"2010","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.jri.2022.103490_bib159","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1095\/biolreprod.105.047332","article-title":"Low oxygen concentrations inhibit trophoblast cell invasion from early gestation placental explants via alterations in levels of the urokinase plasminogen activator system","volume":"74","author":"Lash","year":"2006","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.jri.2022.103490_bib160","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejogrb.2013.12.030","article-title":"Plasminogen activator inhibitor-1 4g\/5g and the mthfr 677c\/t polymorphisms and susceptibility to polycystic ovary syndrome: A meta-analysis","volume":"175","author":"Lee","year":"2014","journal-title":"Eur. J. Obstet., Gynecol., Reprod. Biol."},{"key":"10.1016\/j.jri.2022.103490_bib161","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/01.AOG.0000199953.27961.f9","article-title":"Plasminogen activator inhibitor 1 gene polymorphism and gestational diabetes mellitus","volume":"107","author":"Leipold","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jri.2022.103490_bib162","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.12659\/MSM.892898","article-title":"Meta-analysis of the association between plasminogen activator inhibitor-1 4g\/5g polymorphism and recurrent pregnancy loss","volume":"21","author":"Li","year":"2015","journal-title":"Med. Sci. Monit.: Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.jri.2022.103490_bib163","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10815-013-0171-2","article-title":"Plasminogen activator inhibitor-1 -675 4g\/5g polymorphism and polycystic ovary syndrome risk: A meta analysis","volume":"31","author":"Liu","year":"2014","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.jri.2022.103490_bib164","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1046\/j.1432-1033.2003.03453.x","article-title":"Plasminogen activator inhibitor type-1 inhibits insulin signaling by competing with alphavbeta3 integrin for vitronectin binding","volume":"270","author":"L\u00f3pez-Alemany","year":"2003","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jri.2022.103490_bib165","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1210\/jc.2010-1662","article-title":"Inflammatory mediators and glucose in pregnancy: Results from a subset of the hyperglycemia and adverse pregnancy outcome (hapo) study. The","volume":"95","author":"Lowe","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jri.2022.103490_bib166","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/10641955.2019.1577435","article-title":"Longitudinal assessment of d-dimer and plasminogen activator inhibitor type-1 plasma levels in pregnant women with risk factors for preeclampsia","volume":"38","author":"Lucena","year":"2019","journal-title":"Hypertens. Pregnancy"},{"key":"10.1016\/j.jri.2022.103490_bib167","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.thromres.2012.01.017","article-title":"Pregnancy-related venous thromboembolism: Risk and the effect of thromboprophylaxis","volume":"129","author":"Lussana","year":"2012","journal-title":"Thromb. Res"},{"issue":"Suppl 8A","key":"10.1016\/j.jri.2022.103490_bib168","doi-asserted-by":"crossref","first-page":"62s","DOI":"10.1016\/j.amjmed.2003.08.014","article-title":"Effect of plasminogen activator inhibitor-1 in diabetes mellitus and cardiovascular disease","volume":"115","author":"Lyon","year":"2003","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jri.2022.103490_bib169","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/gtmb.2011.0173","article-title":"Detection of thrombophilic mutations related to spontaneous abortions by a multiplex snapshot method","volume":"16","author":"Madjunkova","year":"2012","journal-title":"Genet. Test. Mol. Biomark."},{"key":"10.1016\/j.jri.2022.103490_bib170","first-page":"246","article-title":"Plasminogen activator inhibitor 1 4g\/5g and -844g\/a variants in idiopathic recurrent pregnancy loss","volume":"70","author":"Magdoud","year":"2013"},{"key":"10.1016\/j.jri.2022.103490_bib171","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1210\/jc.2010-2279","article-title":"Coagulation and fibrinolytic disturbances in women with polycystic ovary syndrome","volume":"96","author":"Manner\u00e5s-Holm","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jri.2022.103490_bib172","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1055\/s-0038-1649834","article-title":"Environmental and genetic factors in relation to elevated circulating levels of plasminogen activator inhibitor-1 in caucasian patients with non-insulin-dependent diabetes mellitus","volume":"74","author":"Mansfield","year":"1995","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jri.2022.103490_bib173","doi-asserted-by":"crossref","first-page":"149","DOI":"10.6026\/97320630013149","article-title":"Polymorphism of the pai-1gene (4g\/5g) may be linked with polycystic ovary syndrome and associated pregnancy disorders in south indian women","volume":"13","author":"Mary","year":"2017","journal-title":"Bioinformation"},{"key":"10.1016\/j.jri.2022.103490_bib174","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.8755-8920.2000.440204.x","article-title":"Autoimmunity in endometriosis: Relevance to infertility","volume":"44","author":"Mathur","year":"2000","journal-title":"Am. J. Reprod. Immunol. (N. Y., N. Y.: 1989)"},{"key":"10.1016\/j.jri.2022.103490_bib175","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/cen.12325","article-title":"Maternal, umbilical arterial and umbilical venous 25-hydroxyvitamin d and adipocytokine concentrations in pregnancies with and without gestational diabetes","volume":"80","author":"Mcmanus","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.jri.2022.103490_bib176","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.placenta.2007.04.005","article-title":"Role of hypoxia-inducible transcription factors 1alpha and 2alpha in the regulation of plasminogen activator inhibitor-1 expression in a human trophoblast cell line","volume":"28","author":"Meade","year":"2007","journal-title":"Placenta"},{"key":"10.1016\/j.jri.2022.103490_bib177","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12933-018-0776-y","article-title":"Rising plasminogen activator inhibitor-1 and hypoadiponectinemia characterize the cardiometabolic biomarker profile of women with recent gestational diabetes","volume":"17","author":"Mehmood","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"issue":"Suppl 2","key":"10.1016\/j.jri.2022.103490_bib178","first-page":"B161","article-title":"Summary and recommendations of the fourth international workshop-conference on gestational diabetes mellitus","volume":"21","author":"Metzger","year":"1998","journal-title":"Organ. Comm. Diabetes Care"},{"key":"10.1016\/j.jri.2022.103490_bib179","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1053\/j.seminhematol.2007.01.005","article-title":"Pregnancy failure and heritable thrombophilia","volume":"44","author":"Middeldorp","year":"2007","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.jri.2022.103490_bib180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056907","article-title":"Association of plasminogen activator inhibitor-type 1 (-675 4g\/5g) polymorphism with pre-eclampsia: Systematic review","volume":"8","author":"Morgan","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jri.2022.103490_bib181","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.diabres.2007.04.013","article-title":"Fibrinolytic dysfunction after gestation is associated to components of insulin resistance and early type 2 diabetes in latino women with previous gestational diabetes","volume":"78","author":"Morimitsu","year":"2007","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.jri.2022.103490_bib182","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1055\/s-0037-1613083","article-title":"Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: Results from a large population-based study and systematic review","volume":"87","author":"Morrison","year":"2002","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jri.2022.103490_bib183","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11239-007-0175-9","article-title":"The 4g\/5g polymorphism in the plasminogen activator inhibitor-1 gene is not associated with hellp syndrome","volume":"27","author":"Muetze","year":"2009","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.jri.2022.103490_bib184","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/01.CIR.89.1.321","article-title":"Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin. A potential risk factor for vascular disease","volume":"89","author":"Nordt","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.jri.2022.103490_bib185","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","article-title":"Polycystic ovary syndrome","volume":"370","author":"Norman","year":"2007","journal-title":"Lancet (Lond., Engl. )"},{"key":"10.1016\/j.jri.2022.103490_bib186","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1472-6483(10)61634-3","article-title":"Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome?","volume":"9","author":"Orio F","year":"2004","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.jri.2022.103490_bib187","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.fertnstert.2014.06.010","article-title":"Elevation of soluble form of receptor for advanced glycation end products (srage) in recurrent pregnancy losses (rpl): Possible participation of rage in rpl","volume":"102","author":"Ota","year":"2014","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jri.2022.103490_bib188","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/gtmb.2011.0191","article-title":"Recurrent pregnancy loss and its relation to combined parental thrombophilic gene mutations","volume":"16","author":"Ozdemir","year":"2012","journal-title":"Genet. Test. Mol. Biomark."},{"key":"10.1016\/j.jri.2022.103490_bib189","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2337\/diab.44.1.37","article-title":"Determinants of plasminogen activator inhibitor 1 activity in treated niddm and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene","volume":"44","author":"Panahloo","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.jri.2022.103490_bib190","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0049-3848(02)00022-1","article-title":"Plasma and serum levels of d-dimer and their correlations with other hemostatic parameters in pregnancy","volume":"105","author":"Paniccia","year":"2002","journal-title":"Thromb. Res"},{"key":"10.1016\/j.jri.2022.103490_bib191","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.ajog.2005.02.109","article-title":"Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction","volume":"193","author":"Parra","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jri.2022.103490_bib192","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00404-013-2877-x","article-title":"Polymorphisms in mthfr, mthfd, and pai-1 and recurrent miscarriage among north indian women","volume":"288","author":"Parveen","year":"2013","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.jri.2022.103490_bib193","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1034\/j.1600-0412.2003.00085.x","article-title":"Plasminogen activator inhibitor type 1 (pai1) and platelet glycoprotein iiia (pgiiia) polymorphisms in black south africans with pre-eclampsia","volume":"82","author":"Pegoraro","year":"2003","journal-title":"Acta Obstet. Et. Gynecol. Scand."},{"key":"10.1016\/j.jri.2022.103490_bib194","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/01443615.2013.836476","article-title":"Plasminogen activator inhibitor-1, factor v, factor ii and methylenetetrahydrofolate reductase polymorphisms in women with recurrent miscarriage","volume":"34","author":"Pietropolli","year":"2014","journal-title":"J. Obstet. Gynaecol.: J. Inst. Obstet. Gynaecol."},{"key":"10.1016\/j.jri.2022.103490_bib195","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cca.2012.10.060","article-title":"Fibrinolytic system in preeclampsia","volume":"416","author":"Pinheiro","year":"2013","journal-title":"Clin. Chim. Acta; Int. J. Clin. Chem."},{"key":"10.1016\/j.jri.2022.103490_bib196","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0015-0282(16)57001-0","article-title":"Gene regulation of interleukin-1 beta, interleukin-1 receptor type i, and plasminogen activator inhibitor-1 and -2 in human granulosa-luteal cells","volume":"62","author":"Piquette","year":"1994","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jri.2022.103490_bib197","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.thromres.2018.05.017","article-title":"Effects of gestational hypertension and pre-eclampsia in mrna expression of fibrinolysis genes in primary cultured human umbilical vein endothelial cells","volume":"167","author":"Poblete-Naredo","year":"2018","journal-title":"Thromb. Res"},{"key":"10.1016\/j.jri.2022.103490_bib198","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s10815-013-0071-5","article-title":"The association between thrombophilic gene mutations and recurrent pregnancy loss","volume":"30","author":"Poursadegh Zonouzi","year":"2013","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.jri.2022.103490_bib199","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(96)04125-6","article-title":"Increased fetal loss in women with heritable thrombophilia","volume":"348","author":"Preston","year":"1996","journal-title":"Lancet (Lond., Engl. )"},{"key":"10.1016\/j.jri.2022.103490_bib200","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.placenta.2012.05.008","article-title":"The role of interleukin-1\u03b2 in human trophoblast motility","volume":"33","author":"Prutsch","year":"2012","journal-title":"Placenta"},{"key":"10.1016\/j.jri.2022.103490_bib201","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1373\/clinchem.2006.081372","article-title":"Cell-free mrna concentrations of plasminogen activator inhibitor-1 and tissue-type plasminogen activator are increased in the plasma of pregnant women with preeclampsia","volume":"53","author":"Purwosunu","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jri.2022.103490_bib202","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/humrep\/deh571","article-title":"Mrna analysis of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis using a real-time quantitative rt-pcr assay","volume":"20","author":"Ram\u00f3n","year":"2005","journal-title":"Hum. Reprod. (Oxf., Engl. )"},{"key":"10.1016\/j.jri.2022.103490_bib203","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.thromres.2008.02.010","article-title":"Plasminogen activator inhibitor-1 (pai-1) 4g\/5g polymorphism and endometriosis. Influence of pai-1 polymorphism on pai-1 antigen and mrna expression","volume":"122","author":"Ram\u00f3n","year":"2008","journal-title":"Thromb. Res"},{"issue":"Suppl A","key":"10.1016\/j.jri.2022.103490_bib204","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.placenta.2008.11.021","article-title":"Placental stress and pre-eclampsia: A revised view","volume":"30","author":"Redman","year":"2009","journal-title":"Placenta"},{"key":"10.1016\/j.jri.2022.103490_bib205","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1471-0528.1993.tb12982.x","article-title":"Plasminogen activator inhibitors (pai-1 and pai-2) in normal pregnancies, pre-eclampsia and hydatidiform mole","volume":"100","author":"Reith","year":"1993","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.jri.2022.103490_bib206","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1095\/biolreprod.104.038000","article-title":"Activated macrophages inhibit human cytotrophoblast invasiveness in vitro","volume":"73","author":"Renaud","year":"2005","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.jri.2022.103490_bib207","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.diabres.2018.04.008","article-title":"Hyperglycemia in pregnancy and its implications for a woman\u2019s future risk of cardiovascular disease","volume":"145","author":"Retnakaran","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.jri.2022.103490_bib208","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.2337\/dc17-0781","article-title":"Impact of changes over time in adipokines and inflammatory proteins on changes in insulin sensitivity, \u03b2-cell function, and glycemia in women with previous gestational dysglycemia","volume":"40","author":"Retnakaran","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jri.2022.103490_bib209","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-2007-1016248","article-title":"Endothelial dysfunction in preeclampsia","volume":"16","author":"Roberts","year":"1998","journal-title":"Semin. Reprod. Endocrinol."},{"key":"10.1016\/j.jri.2022.103490_bib210","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(00)03577-7","article-title":"Pathogenesis and genetics of pre-eclampsia","volume":"357","author":"Roberts","year":"2001","journal-title":"Lancet (Lond., Engl. )"},{"key":"10.1016\/j.jri.2022.103490_bib211","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/01.HYP.0000188408.49896.c5","article-title":"Preeclampsia: Recent insights","volume":"46","author":"Roberts","year":"2005","journal-title":"Hypertens. (Dallas, Tex.: 1979)"},{"key":"10.1016\/j.jri.2022.103490_bib212","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1067\/mob.2002.126280","article-title":"Levels of plasminogen activators and their inhibitors in maternal and umbilical cord plasma in severe preeclampsia","volume":"187","author":"Roes","year":"2002","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jri.2022.103490_bib213","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/cvr\/cvn341","article-title":"Effects of hypoxia-induced intrauterine growth restriction on cardiopulmonary structure and function during adulthood","volume":"81","author":"Rueda-Clausen","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jri.2022.103490_bib214","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1538-7836.2012.04700.x","article-title":"The pai-1 4g\/5g polymorphism is not associated with an increased risk of adverse pregnancy outcome in asymptomatic nulliparous women","volume":"10","author":"Said","year":"2012","journal-title":"J. Thromb. Haemost.: JTH"},{"key":"10.1016\/j.jri.2022.103490_bib215","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.cb.04.110188.000521","article-title":"Cell-associated plasminogen activation: Regulation and physiological functions","volume":"4","author":"Saksela","year":"1988","journal-title":"Annu. Rev. Cell Biol."},{"key":"10.1016\/j.jri.2022.103490_bib216","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/aji.12516","article-title":"Plasminogen activator inhibitor-1 4g\/5g polymorphism is associated with reproductive failure: Metabolic, hormonal, and immune profiles","volume":"76","author":"Salazar Garcia","year":"2016","journal-title":"Am. J. Reprod. Immunol. (N. Y., N. Y.: 1989)"},{"key":"10.1016\/j.jri.2022.103490_bib217","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3109\/09513590.2013.819086","article-title":"Correlation between plasminogen activator inhibitor-1 (pai-1) promoter 4g\/5g polymorphism and metabolic\/proinflammatory factors in polycystic ovary syndrome","volume":"29","author":"Sales","year":"2013","journal-title":"Gynecol. Endocrinol.: Off. J. Int. Soc. Gynecol. Endocrinol."},{"key":"10.1016\/j.jri.2022.103490_bib218","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1024\/0301-1526\/a000171","article-title":"Arterial stiffness, inflammatory and pro-atherogenic markers in gestational diabetes mellitus. VASA","volume":"41","author":"Salmi","year":"2012","journal-title":"Z. fur Gefasskrankh."},{"key":"10.1016\/j.jri.2022.103490_bib219","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1083\/jcb.109.5.2471","article-title":"Plasminogen activators in tissue remodeling and invasion: Mrna localization in mouse ovaries and implanting embryos. The","volume":"109","author":"Sappino","year":"1989","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jri.2022.103490_bib220","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1538-7836.2008.02840.x","article-title":"Variations in fibrinolytic parameters and inhibin-a in pregnancy: Related hypertensive disorders","volume":"6","author":"Sartori","year":"2008","journal-title":"J. Thromb. Haemost.: JTH"},{"key":"10.1016\/j.jri.2022.103490_bib221","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/00019501-199611000-00004","article-title":"Synergistic augmentation of expression of plasminogen activator inhibitor type-1 induced by insulin, very-low-density lipoproteins, and fatty acids","volume":"7","author":"Schneider","year":"1996","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.jri.2022.103490_bib222","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.2337\/dc12-0638","article-title":"Pai-1 and diabetes: A journey from the bench to the bedside","volume":"35","author":"Schneider","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jri.2022.103490_bib223","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1096\/fj.14-266387","article-title":"Heritable iugr and adult metabolic syndrome are reversible and associated with alterations in the metabolome following dietary supplementation of 1-carbon intermediates","volume":"29","author":"Seferovic","year":"2015","journal-title":"FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.jri.2022.103490_bib224","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7124186","article-title":"Increased umbilical cord pai-1 levels in placental insufficiency are associated with fetal hypoxia and angiogenesis","volume":"2016","author":"Seferovic","year":"2016","journal-title":"Dis. Markers"},{"key":"10.1016\/j.jri.2022.103490_bib225","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/jama.1966.03110190127032","article-title":"Pericardial endometriosis. An experimental study in dogs","volume":"198","author":"Sensenig","year":"1966","journal-title":"Jama"},{"key":"10.1016\/j.jri.2022.103490_bib226","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4137\/CMPed.S40070","article-title":"Intrauterine growth restriction: Antenatal and postnatal aspects","volume":"10","author":"Sharma","year":"2016","journal-title":"Clin. Med. Insights Pediatr.."},{"key":"10.1016\/j.jri.2022.103490_bib227","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1055\/s-2007-994947","article-title":"Uteroplacental hemostasis in intrauterine fetal growth retardation","volume":"25","author":"Sheppard","year":"1999","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.jri.2022.103490_bib228","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/09513590601005805","article-title":"Comparison of fibrinolytic and metabolic system parameters in obese patients with polycystic ovary syndrome and women with simple obesity","volume":"22","author":"S\u0142opie\u0144","year":"2006","journal-title":"Gynecol. Endocrinol.: Off. J. Int. Soc. Gynecol. Endocrinol."},{"key":"10.1016\/j.jri.2022.103490_bib229","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1387\/ijdb.140083ms","article-title":"Adaptive mechanisms controlling uterine spiral artery remodeling during the establishment of pregnancy","volume":"58","author":"Soares","year":"2014","journal-title":"Int. J. Dev. Biol."},{"key":"10.1016\/j.jri.2022.103490_bib230","first-page":"324","article-title":"Association of ace, pai-1 and coagulation factor xiii gene polymorphisms with recurrent spontaneous abortion in iranian patients %j jri","volume":"7","author":"Soltanghoraee","year":"2007","journal-title":"J. Reprod. Infertil."},{"key":"10.1016\/j.jri.2022.103490_bib231","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/GRF.0b013e31802f1c28","article-title":"Evaluation and management of recurrent early pregnancy loss","volume":"50","author":"Stephenson","year":"2007","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.jri.2022.103490_bib232","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1055\/s-0038-1661167","article-title":"Haemostasis in normal pregnancy","volume":"52","author":"Stirling","year":"1984","journal-title":"Thromb. Haemost."},{"issue":"16","key":"10.1016\/j.jri.2022.103490_bib233","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/ar4484","article-title":"Interaction of the endocrine system with inflammation: A function of energy and volume regulation","volume":"16","author":"Straub","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jri.2022.103490_bib234","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1160\/TH12-08-0584","article-title":"Genetic association studies of ace and pai-1 genes in women with recurrent pregnancy loss: A systematic review and meta-analysis","volume":"109","author":"Su","year":"2013","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jri.2022.103490_bib235","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/aji.12099","article-title":"Recurrent pregnancy loss, plasminogen activator inhibitor-1 (-675) 4g\/5g polymorphism and antiphospholipid antibodies in czech women","volume":"70","author":"Subrt","year":"2013","journal-title":"Am. J. Reprod. Immunol. (N. Y., N. Y.: 1989)"},{"key":"10.1016\/j.jri.2022.103490_bib236","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF03346557","article-title":"Angiotensin-converting enzyme d\/i and plasminogen activator inhibitor-1 4g\/5g gene polymorphisms are associated with increased risk of spontaneous abortions in polycystic ovarian syndrome","volume":"33","author":"Sun","year":"2010","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.jri.2022.103490_bib237","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jpag.2011.06.012","article-title":"High rate of endometriosis recurrence in young women","volume":"24","author":"Tandoi","year":"2011","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"10.1016\/j.jri.2022.103490_bib238","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/107602960501100415","article-title":"Coagulation and fibrinolysis in preeclampsia and neonates","volume":"11","author":"Tanjung","year":"2005","journal-title":"Clin. Appl. Thromb. \/Hemost.: Off. J. Int. Acad. Clin. Appl. Thromb. \/Hemost."},{"key":"10.1016\/j.jri.2022.103490_bib239","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jsgi.2003.12.002","article-title":"Polymorphisms of thrombophilic and vasoactive genes and severe preeclampsia: A pilot study","volume":"11","author":"Tempfer","year":"2004","journal-title":"J. Soc. Gynecol. Investig."},{"key":"10.1016\/j.jri.2022.103490_bib240","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/aogs.12366","article-title":"Angiogenic factors and uterine doppler velocimetry in early- and late-onset preeclampsia","volume":"93","author":"Tobinaga","year":"2014","journal-title":"Acta Obstet. Et. Gynecol. Scand."},{"key":"10.1016\/j.jri.2022.103490_bib241","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/humupd\/dmr025","article-title":"Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome","volume":"17","author":"Toulis","year":"2011","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.jri.2022.103490_bib242","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4103\/1119-3077.183256","article-title":"Early pregnancy plasminogen activator inhibitor-1 levels in nigerian women and its relationship with preeclampsia","volume":"20","author":"Udenze","year":"2017","journal-title":"Niger. J. Clin. Pract."},{"key":"10.1016\/j.jri.2022.103490_bib243","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0026-0495(86)90209-X","article-title":"Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects","volume":"35","author":"Vague","year":"1986","journal-title":"Metab.: Clin. Exp."},{"key":"10.1016\/j.jri.2022.103490_bib244","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrendo.2013.255","article-title":"Endometriosis: Pathogenesis and treatment","volume":"10","author":"Vercellini","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jri.2022.103490_bib245","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/549748","article-title":"Role of adipokines and other inflammatory mediators in gestational diabetes mellitus and previous gestational diabetes mellitus","volume":"2012","author":"Vrachnis","year":"2012","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.jri.2022.103490_bib246","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00404-015-3678-1","article-title":"4g\/5g polymorphism of plasminogen activator inhibitor-1 gene is associated with polycystic ovary syndrome in chinese patients: A meta-analysis","volume":"292","author":"Wang","year":"2015","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.jri.2022.103490_bib247","first-page":"405","article-title":"The genetics of pre-eclampsia and other hypertensive disorders of pregnancy. Best practice & research","volume":"25","author":"Williams","year":"2011","journal-title":"Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.jri.2022.103490_bib248","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1055\/s-0038-1661154","article-title":"The fast inhibitor of tissue plasminogen activator in plasma during pregnancy","volume":"52","author":"Wiman","year":"1984","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jri.2022.103490_bib249","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.2337\/diacare.27.7.1721","article-title":"Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus","volume":"27","author":"Winzer","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jri.2022.103490_bib250","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00404-005-0117-8","article-title":"Correlation between plasminogen activator inhibitor-1 4g\/5g polymorphism and pre-eclampsia: An appraisal","volume":"273","author":"Wiwanitkit","year":"2006","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.jri.2022.103490_bib251","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000077821","article-title":"Recurrent pregnancy loss and its relation to fv leiden, fii g20210a and polymorphisms of plasminogen activator and plasminogen activator inhibitor","volume":"33","author":"Wolf","year":"2003","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"10.1016\/j.jri.2022.103490_bib252","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s100380050200","article-title":"The 4g\/5g polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia","volume":"45","author":"Yamada","year":"2000","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.jri.2022.103490_bib253","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2020.103186","article-title":"Decreased hla-c1 alleles in couples of kir2dl2 positive women with recurrent pregnancy loss","volume":"142","author":"Yang","year":"2020","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2022.103490_bib254","first-page":"1095","article-title":"Prevalence of thrombosis-related DNA polymorphisms in a healthy greek population","volume":"26","author":"Yapijakis","year":"2012","journal-title":"vivo (Athens, Greece)"},{"key":"10.1016\/j.jri.2022.103490_bib255","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/858293","article-title":"Functional stability of plasminogen activator inhibitor-1","volume":"2014","author":"Yasar Yildiz","year":"2014","journal-title":"Sci. World J."},{"key":"10.1016\/j.jri.2022.103490_bib256","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/ijms18081651","article-title":"Role of plasminogen activator inhibitor type 1 in pathologies of female reproductive diseases","volume":"18","author":"Ye","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jri.2022.103490_bib257","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1210\/jc.2003-030874","article-title":"Hepatocyte growth factor\/met system promotes endometrial and endometriotic stromal cell invasion via autocrine and paracrine pathways","volume":"89","author":"Yoshida","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jri.2022.103490_bib258","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/biomedicines8110467","article-title":"Relaxin-2 may suppress endometriosis by reducing fibrosis, scar formation, and inflammation","volume":"8","author":"Yoshino","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.jri.2022.103490_bib259","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1046\/j.1523-1747.2003.12564.x","article-title":"Mechanisms of hypoxic regulation of plasminogen activator inhibitor-1 gene expression in keloid fibroblasts","volume":"121","author":"Zhang","year":"2003","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jri.2022.103490_bib260","first-page":"2326","article-title":"The -675 4g\/5g polymorphism in the pai-1 gene may not contribute to the risk of pcos","volume":"18","author":"Zhang","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.jri.2022.103490_bib261","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00001703-200106000-00011","article-title":"The genetic basis of endometriosis","volume":"13","author":"Zondervan","year":"2001","journal-title":"Curr. Opin. Obstet. Gynecol."},{"issue":"Suppl 1","key":"10.1016\/j.jri.2022.103490_bib262","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/S0301-2115(03)00168-4","article-title":"Angiogenesis and vasculogenesis in pregnancy","volume":"110","author":"Zygmunt","year":"2003","journal-title":"Eur. J. Obstet., Gynecol., Reprod. Biol."}],"container-title":["Journal of Reproductive Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037822000183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037822000183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T04:31:15Z","timestamp":1759033875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165037822000183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":262,"alternative-id":["S0165037822000183"],"URL":"https:\/\/doi.org\/10.1016\/j.jri.2022.103490","relation":{},"ISSN":["0165-0378"],"issn-type":[{"value":"0165-0378","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of plasminogen activator inhibitor-1 in gynecological and obstetrical diseases: An update review","name":"articletitle","label":"Article Title"},{"value":"Journal of Reproductive Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jri.2022.103490","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103490"}}